Search results
ASCO24: Can Ambrx’s novel ADC break into the metastatic breast cancer market?
Pharmaceutical Technology via Yahoo Finance· 16 hours agoIn ACE-Breast-02, ARX788 managed to prolong progression-free survival (PFS) compared to LC, with...
Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients -...
Nature· 7 days agoTo predict outcome to combination bevacizumab (BVZ) therapy, we employed cell-free DNA (cfDNA) to determine chromosomal instability (CIN), nucleosome footprints (NF) and methylation profiles ...
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 2 days agoThese safety results are in keeping with the known toxicities of Enhertu and Perjeta....
N95 respirator gets top billing in stopping SARS-CoV-2 viral leakage into the air
Center for Infectious Disease Research and Policy· 6 hours agoResearchers who compared the ability of cloth and surgical masks and KN95 and N95 respirators to...
Hypertension, albuminuria risks are no worse for kidney donors than for non-donors: Study
Medical Xpress· 5 days agoLiving kidney donors and non-donors have similar risks for hypertension and albuminuria, according...
Early use of antivirals linked to reduced risk of long COVID
Center for Infectious Disease Research and Policy· 23 hours agoOverall early oral antiviral drugs reduced long-COVID risk 23% (risk ratio [RR] 0.77; 95% confidence...
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial...
KOLR - KSFX Ozarks· 3 days agoJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term follow-up results, including the first-ever overall survival (OS) findings, from the Phase 2b HERIZON-BTC-01 clinical trial ...
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following...
Digital Journal· 1 day agoMedicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, presented updated clinical ...
Exploring high-quality microbial genomes by assembling short-reads with long-range connectivity -...
Nature· 5 days agoHere, the authors develop Pangaea, an assembler that uses short-reads with long-range connectivity to create high-quality microbial genomes affordably, showing it outperforms existing methods ...
Infarct size does not affect treatment effect of early versus late direct oral anticoagulant...
Medical Xpress· 6 days agoFor individuals with minor, moderate, or major stroke, the treatment effect of early versus late...